SYBLEU INC. Patent Applications Rejected
2 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2021-12-02: Application 17541088; Invention CANCER THERAPY BY INTRATUMORAL INJECTION OF A CHEMOTHERAPEUTIC AGENT IN COMBINATION WITH A BIOACTIVE IMMUNOSTIMULATORY AGENT; Applicant SYBLEU INC.; Status Abandoned -- Failure to Respond to an Office Action.
- 2021-07-14: Application 17376084; Invention QUALITY OF A CELLULAR GRAFT; Applicant Sybleu, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2021-12-02 | 17541088 | CANCER THERAPY BY INTRATUMORAL INJECTION OF A CHEMOTHERAPEUTIC AGENT IN COMBINATION WITH A BIOACTIVE IMMUNOSTIMULATORY AGENT | SYBLEU INC. | Abandoned -- Failure to Respond to an Office Action | US20220168240A1 | David KOOS | United States | HOU, FRANK S |
| 2021-07-14 | 17376084 | QUALITY OF A CELLULAR GRAFT | Sybleu, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220031912A1 | David Koos | United States | NGUYEN, NGHI V |